{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:31:33Z","timestamp":1792740693946,"version":"4.5.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1038\/s41401-020-00558-4","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T08:03:26Z","timestamp":1605773006000},"page":"1409-1421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington\u2019s disease via suppressing MAPKs and NF-\u03baB pathways in the striatum"],"prefix":"10.1038","volume":"42","author":[{"given":"Xiong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-feng","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-he","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"558_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuropharm.2016.04.041","volume":"108","author":"C Walter","year":"2016","unstructured":"Walter C, Clemens LE, Muller AJ, Fallier-Becker P, Proikas-Cezanne T, Riess O, et al. Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitro. Neuropharmacology. 2016;108:24\u201338.","journal-title":"Neuropharmacology."},{"key":"558_CR2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E. Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev. 2010;90:905\u201381.","journal-title":"Physiol Rev"},{"key":"558_CR3","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/arclin\/acx086","volume":"32","author":"JS Snowden","year":"2017","unstructured":"Snowden JS. The neuropsychology of Huntington\u2019s disease. Arch Clin Neuropsychol. 2017;32:876\u201387.","journal-title":"Arch Clin Neuropsychol"},{"key":"558_CR4","doi-asserted-by":"publisher","first-page":"E1618","DOI":"10.1073\/pnas.1716871115","volume":"115","author":"Z Dargaei","year":"2018","unstructured":"Dargaei Z, Bang JY, Mahadevan V, Khademullah CS, Bedard S, Parfitt GM, et al. Restoring GABAergic inhibition rescues memory deficits in a Huntington\u2019s disease mouse model. Proc Natl Acad Sci USA. 2018;115:E1618\u201326.","journal-title":"Proc Natl Acad Sci USA"},{"key":"558_CR5","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1523\/JNEUROSCI.1739-17.2017","volume":"38","author":"MD Sepers","year":"2018","unstructured":"Sepers MD, Smith-Dijak A, LeDue J, Kolodziejczyk K, Mackie K, Raymond LA. Endocannabinoid-specific impairment in synaptic plasticity in striatum of Huntington\u2019s disease mouse model. J Neurosci. 2018;38:544\u201354.","journal-title":"J Neurosci"},{"key":"558_CR6","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington disease. Nat Rev Dis Prim. 2015;1:15005.","journal-title":"Nat Rev Dis Prim"},{"key":"558_CR7","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1007\/s12035-015-9230-2","volume":"53","author":"M Jang","year":"2015","unstructured":"Jang M, Cho IH. Sulforaphane ameliorates 3-nitropropionic acid-induced striatal toxicity by activating the Keap1-Nrf2-ARE pathway and inhibiting the MAPKs and NF-\u03baB pathways. Mol Neurobiol. 2015;53:2619\u201335.","journal-title":"Mol Neurobiol"},{"key":"558_CR8","doi-asserted-by":"publisher","first-page":"9.48","DOI":"10.1002\/0471142301.ns0948s67","volume":"67","author":"E Brouillet","year":"2014","unstructured":"Brouillet E. The 3\u2010NP model of striatal neurodegeneration. Curr Protoc Neurosci. 2014;67:9.48.","journal-title":"Curr Protoc Neurosci"},{"key":"558_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.physbeh.2015.12.015","volume":"155","author":"S Jamwal","year":"2016","unstructured":"Jamwal S, Kumar P. Spermidine ameliorates 3-nitropropionic acid (3-NP)-induced striatal toxicity: Possible role of oxidative stress, neuroinflammation, and neurotransmitters. Physiol Behav. 2016;155:180\u20137.","journal-title":"Physiol Behav"},{"key":"558_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.biopha.2016.11.111","volume":"86","author":"L Wang","year":"2017","unstructured":"Wang L, Wang J, Yang L, Zhou SM, Guan SY, Yang LK, et al. Effect of Praeruptorin C on 3-nitropropionic acid induced Huntington's disease-like symptoms in mice. Biomed Pharmacother. 2017;86:81\u20137.","journal-title":"Biomed Pharmacother"},{"key":"558_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biopha.2015.11.009","volume":"77","author":"SB Dhadde","year":"2016","unstructured":"Dhadde SB, Nagakannan P, Roopesh M, Anand Kumar SR, Thippeswamy BS, Veerapur VP, et al. Effect of embelin against 3-nitropropionic acid-induced Huntington\u2019s disease in rats. Biomed Pharmacother. 2016;77:52\u20138.","journal-title":"Biomed Pharmacother"},{"key":"558_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bbi.2014.01.015","volume":"38","author":"M Jang","year":"2014","unstructured":"Jang M, Lee MJ, Cho IH. Ethyl pyruvate ameliorates 3-nitropropionic acid-induced striatal toxicity through anti-neuronal cell death and anti-inflammatory mechanisms. Brain Behav Immun. 2014;38:151\u201365.","journal-title":"Brain Behav Immun"},{"key":"558_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-016-0447-7","volume":"40","author":"JL Lai","year":"2017","unstructured":"Lai JL, Liu YH, Liu C, Qi MP, Liu RN, Zhu XF, et al. Indirubin inhibits LPS-induced inflammation via TLR4 abrogation mediated by the NF-\u03baB and MAPK signaling pathways. Inflammation 2017;40:1\u201312.","journal-title":"Inflammation"},{"key":"558_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.pneurobio.2005.10.008","volume":"77","author":"JJ Haddad","year":"2005","unstructured":"Haddad JJ. N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention? Prog Neurobiol. 2005;77:252\u201382.","journal-title":"Prog Neurobiol"},{"key":"558_CR15","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1177\/0960327119842635","volume":"38","author":"D Jiao","year":"2019","unstructured":"Jiao D, Jiang Q, Liu Y, Ji L. Nephroprotective effect of wogonin against cadmium-induced nephrotoxicity via inhibition of oxidative stress-induced MAPK and NF-kB pathway in Sprague Dawley rats. Hum Exp Toxicol. 2019;38:1082\u201391.","journal-title":"Hum Exp Toxicol"},{"key":"558_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuroscience.2018.04.034","volume":"383","author":"RA Santana-Martinez","year":"2018","unstructured":"Santana-Martinez RA, Leon-Contreras JC, Barrera-Oviedo D, Pedraza-Chaverri J, Hernandez-Pando R, Maldonado PD. Sustained activation of JNK induced by quinolinic acid alters the BDNF\/TrkB axis in the rat striatum. Neuroscience 2018;383:22\u201332.","journal-title":"Neuroscience"},{"key":"558_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1742-4658.2009.07367.x","volume":"277","author":"S Subramaniam","year":"2010","unstructured":"Subramaniam S, Unsicker K. ERK and cell death: ERK1\/2 in neuronal death. FEBS J. 2010;277:22\u20139.","journal-title":"FEBS J"},{"key":"558_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/bies.201100116","volume":"34","author":"L Bodai","year":"2012","unstructured":"Bodai L, Marsh JL. A novel target for Huntington\u2019s disease: ERK at the crossroads of signaling. The ERK signaling pathway is implicated in Huntington\u2019s disease and its upregulation ameliorates pathology. Bioessays. 2012;34:142\u20138.","journal-title":"Bioessays."},{"key":"558_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.nbd.2012.01.011","volume":"46","author":"FR Fusco","year":"2012","unstructured":"Fusco FR, Anzilotti S, Giampa C, Dato C, Laurenti D, Leuti A, et al. Changes in the expression of extracellular regulated kinase (ERK1\/2) in the R6\/2 mouse model of Huntington\u2019s disease after phosphodiesterase IV inhibition. Neurobiol Dis. 2012;46:225\u201333.","journal-title":"Neurobiol Dis"},{"key":"558_CR20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1159\/000491889","volume":"48","author":"IO Yusuf","year":"2018","unstructured":"Yusuf IO, Cheng PH, Chen HM, Chang YF, Chang CY, Yang HI, et al. Fibroblast growth factor 9 suppresses striatal cell death dominantly through ERK signaling in Huntington\u2019s disease. Cell Physiol Biochem. 2018;48:605\u201317.","journal-title":"Cell Physiol Biochem"},{"key":"558_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neulet.2007.09.056","volume":"434","author":"M Napolitano","year":"2008","unstructured":"Napolitano M, Zei D, Centonze D, Palermo R, Bernardi G, Vacca A, et al. NF-\u03baB\/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington\u2019s disease. Neurosci Lett. 2008;434:241\u20136.","journal-title":"Neurosci Lett"},{"key":"558_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/08923973.2016.1267744","volume":"39","author":"KS Wang","year":"2017","unstructured":"Wang KS, Li J, Wang Z, Mi C, Ma J, Piao LX, et al. Artemisinin inhibits inflammatory response via regulating NF-kappaB and MAPK signaling pathways. Immunopharmacol Immunotoxicol. 2017;39:28\u201336.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"558_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jgr.2017.03.011","volume":"42","author":"KH Kim","year":"2018","unstructured":"Kim KH, Lee D, Lee HL, Kim C-E, Jung K, Kang KS. Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions. J Ginseng Res. 2018;42:239\u201347.","journal-title":"J Ginseng Res"},{"key":"558_CR24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.neuropharm.2015.10.024","volume":"101","author":"T Zhou","year":"2016","unstructured":"Zhou T, Zu G, Zhang X, Wang X, Li S, Gong X, et al. Neuroprotective effects of ginsenoside Rg1 through the Wnt\/\u03b2-catenin signaling pathway in both in vivo and in vitro models of Parkinson\u2019s disease. Neuropharmacology. 2016;101:480\u20139.","journal-title":"Neuropharmacology."},{"key":"558_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.toxlet.2015.12.005","volume":"243","author":"Y Heng","year":"2016","unstructured":"Heng Y, Zhang QS, Mu Z, Hu JF, Yuan YH, Chen NH. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting alpha-synuclein abnormalities in the substantia nigra. Toxicol Lett. 2016;243:7\u201321.","journal-title":"Toxicol Lett"},{"key":"558_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000431100","volume":"96","author":"W Jiang","year":"2015","unstructured":"Jiang W, Wang Z, Jiang Y, Lu M, Li X. Ginsenoside Rg1 ameliorates motor function in an animal model of Parkinson\u2019s disease. Pharmacology. 2015;96:25\u201331.","journal-title":"Pharmacology."},{"key":"558_CR27","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1476-5381.2009.00361.x","volume":"158","author":"L Xu","year":"2009","unstructured":"Xu L, Chen WF, Wong MS. Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson\u2019s disease through the IGF-I receptor signalling pathway. Br J Pharmacol. 2009;158:738\u201348.","journal-title":"Br J Pharmacol"},{"key":"558_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neuint.2010.11.004","volume":"58","author":"Q Liu","year":"2011","unstructured":"Liu Q, Kou JP, Yu BY. Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-kappaB activation. Neurochem Int. 2011;58:119\u201325.","journal-title":"Neurochem Int"},{"key":"558_CR29","doi-asserted-by":"publisher","first-page":"e101291","DOI":"10.1371\/journal.pone.0101291","volume":"9","author":"J Zhu","year":"2014","unstructured":"Zhu J, Mu X, Zeng J, Xu C, Liu J, Zhang M, et al. Ginsenoside Rg1 prevents cognitive impairment and hippocampus senescence in a rat model of D-galactose-induced aging. PLoS One. 2014;9:e101291.","journal-title":"PLoS One"},{"key":"558_CR30","doi-asserted-by":"publisher","first-page":"6473506","DOI":"10.1155\/2017\/6473506","volume":"2017","author":"L Nie","year":"2017","unstructured":"Nie L, Xia J, Li H, Zhang Z, Yang Y, Huang X, et al. Ginsenoside Rg1 ameliorates behavioral abnormalities and modulates the hippocampal proteomic change in triple transgenic mice of Alzheimer\u2019s disease. Oxid Med Cell Longev. 2017;2017:6473506.","journal-title":"Oxid Med Cell Longev"},{"key":"558_CR31","first-page":"237207","volume":"2013","author":"M Jang","year":"2013","unstructured":"Jang M, Lee MJ, Kim CS, Cho IH. Korean red ginseng extract attenuates 3-nitropropionic acid-induced Huntington\u2019s-like symptoms. Evid Based Complement Altern Med. 2013;2013:237207.","journal-title":"Evid Based Complement Altern Med"},{"key":"558_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/aps.2014.107","volume":"36","author":"Y Gao","year":"2015","unstructured":"Gao Y, Chu SF, Li JP, Zhang Z, Yan JQ, Wen ZL, et al. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease. Acta Pharmacol Sin. 2015;36:311\u201322.","journal-title":"Acta Pharmacol Sin"},{"key":"558_CR33","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1007\/s12035-016-9822-5","volume":"54","author":"S Jamwal","year":"2016","unstructured":"Jamwal S, Kumar P. L-theanine, a component of green tea prevents 3-nitropropionic acid (3-NP)-induced striatal toxicity by modulating nitric oxide pathway. Mol Neurobiol. 2016;54:2327\u201337.","journal-title":"Mol Neurobiol"},{"key":"558_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.psyneuen.2017.08.015","volume":"85","author":"F Navarrete","year":"2017","unstructured":"Navarrete F, Garcia-Gutierrez MS, Laborda J, Manzanares J. Deletion of Dlk2 increases the vulnerability to anxiety-like behaviors and impairs the anxiolytic action of alprazolam. Psychoneuroendocrinology. 2017;85:134\u201341.","journal-title":"Psychoneuroendocrinology."},{"key":"558_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neulet.2016.12.010","volume":"638","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Jiang YY, Shao S, Zhang C, Liu FY, Wan Y, et al. Inhibiting medial septal cholinergic neurons with DREADD alleviated anxiety-like behaviors in mice. Neurosci Lett. 2017;638:139\u201344.","journal-title":"Neurosci Lett"},{"key":"558_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2018.02.003","volume":"288","author":"L Wen","year":"2018","unstructured":"Wen L, Zhang QS, Heng Y, Chen Y, Wang S, Yuan YH, et al. NLRP3 inflammasome activation in the thymus of MPTP-induced Parkinsonian mouse model. Toxicol Lett. 2018;288:1\u20138.","journal-title":"Toxicol Lett"},{"key":"558_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature03480","volume":"435","author":"J Kroymann","year":"2005","unstructured":"Kroymann J, Mitchell-Olds T. Epistasis and balanced polymorphism influencing complex trait variation. Nature. 2005;435:95\u20138.","journal-title":"Nature."},{"key":"558_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05682-6","volume":"7","author":"S Feng","year":"2017","unstructured":"Feng S, Xing C, Shen T, Qiao Y, Wang R, Chen J, et al. Abnormal paraventricular nucleus of hypothalamus and growth retardation associated with loss of nuclear receptor Gene COUP-TFII. Sci Rep. 2017;7:5282.","journal-title":"Sci Rep."},{"key":"558_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejphar.2013.03.051","volume":"710","author":"XY Song","year":"2013","unstructured":"Song XY, Hu JF, Chu SF, Zhang Z, Xu S, Yuan YH, et al. Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3\u03b2\/tau signaling pathway and the A\u03b2 formation prevention in rats. Eur J Pharmacol. 2013;710:29\u201338.","journal-title":"Eur J Pharmacol"},{"key":"558_CR40","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10571-019-00669-5","volume":"39","author":"C Chen","year":"2019","unstructured":"Chen C, Chu SF, Ai QD, Zhang Z, Guan FF, Wang SS, et al. CKLF1 aggravates focal cerebral ischemia injury at early stage partly by modulating microglia\/macrophage toward M1 polarization through CCR4. Cell Mol Neurobiol. 2019;39:651\u201369.","journal-title":"Cell Mol Neurobiol"},{"key":"558_CR41","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1515\/hsz-2013-0142","volume":"394","author":"H Sun","year":"2013","unstructured":"Sun H, Tang Y, Guan X, Li L, Wang D. Effects of selective hypothermia on blood-brain barrier integrity and tight junction protein expression levels after intracerebral hemorrhage in rats. Biol Chem. 2013;394:1317\u201324.","journal-title":"Biol Chem"},{"key":"558_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1432-5","volume":"16","author":"Y Zuo","year":"2019","unstructured":"Zuo Y, Huang L, Enkhjargal B, Xu W, Umut O, Travis ZD, et al. Activation of retinoid X receptor by bexarotene attenuates neuroinflammation via PPAR\u03b3\/SIRT6\/FoxO3a pathway after subarachnoid hemorrhage in rats. J Neuroinflammation. 2019;16:47.","journal-title":"J Neuroinflammation"},{"key":"558_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.nbd.2017.05.011","volume":"105","author":"I Sebastianutto","year":"2017","unstructured":"Sebastianutto I, Cenci MA, Fieblinger T. Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington\u2019s disease. Neurobiol Dis. 2017;105:117\u201331.","journal-title":"Neurobiol Dis"},{"key":"558_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/srep18840","volume":"6","author":"KJ Cho","year":"2016","unstructured":"Cho KJ, Cheon SY, Kim GW. Apoptosis signal-regulating kinase 1 mediates striatal degeneration via the regulation of C1q. Sci Rep. 2016;6:18840.","journal-title":"Sci Rep."},{"key":"558_CR45","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik A, Genov\u00e9 G, M\u00e4e M, Nisancioglu MH, Wallgard E, Niaudet C, et al. Pericytes regulate the blood\u2013brain barrier. Nature. 2010;468:557\u201361.","journal-title":"Nature."},{"key":"558_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.coph.2015.09.008","volume":"26","author":"R Andre","year":"2016","unstructured":"Andre R, Carty L, Tabrizi SJ. Disruption of immune cell function by mutant huntingtin in Huntington\u2019s disease pathogenesis. Curr Opin Pharmacol. 2016;26:33\u20138.","journal-title":"Curr Opin Pharmacol"},{"key":"558_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pnpbp.2015.06.008","volume":"64","author":"YK Kim","year":"2016","unstructured":"Kim YK, Na KS, Myint AM, Leonard BE. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2016;64:277\u201384.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"558_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","volume":"87","author":"JA Smith","year":"2012","unstructured":"Smith JA, Das A, Ray SK, Banik NL. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012;87:10\u201320.","journal-title":"Brain Res Bull"},{"key":"558_CR49","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pnpbp.2015.02.005","volume":"60","author":"DM Hanna","year":"2015","unstructured":"Hanna DM, Tadros MG, Khalifa AE. ADIOL protects against 3-NP-induced neurotoxicity in rats: Possible impact of its anti-oxidant, anti-inflammatory and anti-apoptotic actions. Prog Neuropsychopharmacol Biol Psychiatry. 2015;60:36\u201351.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"558_CR50","doi-asserted-by":"publisher","first-page":"a024240","DOI":"10.1101\/cshperspect.a024240","volume":"7","author":"M Jimenez-Sanchez","year":"2017","unstructured":"Jimenez-Sanchez M, Licitra F, Underwood BR, Rubinsztein DC. Huntington\u2019s disease: Mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harb Perspect Med. 2017;7:a024240.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"558_CR51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.exger.2017.06.009","volume":"96","author":"A Silva-Palacios","year":"2017","unstructured":"Silva-Palacios A, Ostolga-Chavarr\u00eda M, Buelna-Chontal M, Garibay C, Hern\u00e1ndez-Res\u00e9ndiz S, Rold\u00e1n FJ, et al. 3-NP-induced Huntington\u2019s-like disease impairs Nrf2 activation without loss of cardiac function in aged rats. Exp Gerontol. 2017;96:89\u201398.","journal-title":"Exp Gerontol"},{"key":"558_CR52","doi-asserted-by":"publisher","first-page":"104548","DOI":"10.1016\/j.neuint.2019.104548","volume":"131","author":"EM Elbaz","year":"2019","unstructured":"Elbaz EM, Helmy HS, El-Sahar AE, Saad MA, Sayed RH. Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington\u2019s disease model rats via modulation of the calcium\/calcineurin\/NFATc4 and Wnt\/beta-catenin signalling pathways. Neurochem Int. 2019;131:104548.","journal-title":"Neurochem Int"},{"key":"558_CR53","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/jnr.24507","volume":"97","author":"FM Torres\u2010Cruz","year":"2019","unstructured":"Torres\u2010Cruz FM, Mendoza E, Vivar\u2010Cort\u00e9s IC, Garc\u00eda\u2010Sierra F, Hern\u00e1ndez\u2010Echeagaray E. Do BDNF and NT\u20104\/5 exert synergistic or occlusive effects on corticostriatal transmission in a male mouse model of Huntington\u2019s disease? J Neurosci Res. 2019;97:1665\u201377.","journal-title":"J Neurosci Res"},{"key":"558_CR54","doi-asserted-by":"publisher","first-page":"e0140974","DOI":"10.1371\/journal.pone.0140974","volume":"10","author":"V Sgambato-Faure","year":"2015","unstructured":"Sgambato-Faure V, Qian Y, Forssberg H, Diaz Heijtz R. Motor skill learning is associated with phase-dependent modifications in the striatal cAMP\/PKA\/DARPP-32 signaling pathway in rodents. PLoS One. 2015;10:e0140974.","journal-title":"PLoS One"},{"key":"558_CR55","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.1523\/JNEUROSCI.0195-15.2015","volume":"35","author":"HS Xenias","year":"2015","unstructured":"Xenias HS, Ibanez-Sandoval O, Koos T, Tepper JM. Are striatal tyrosine hydroxylase interneurons dopaminergic? J Neurosci. 2015;35:6584\u201399.","journal-title":"J Neurosci"},{"key":"558_CR56","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11302-018-9609-4","volume":"14","author":"MR Domenici","year":"2018","unstructured":"Domenici MR, Chiodi V, Averna M, Armida M, Pezzola A, Pepponi R, et al. Neuronal adenosine A2A receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington\u2019s disease. Purinergic Signal. 2018;14:235\u201343.","journal-title":"Purinergic Signal"},{"key":"558_CR57","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s11011-018-0252-0","volume":"33","author":"S Ramachandran","year":"2018","unstructured":"Ramachandran S, Thangarajan S. Thymoquinone loaded solid lipid nanoparticles counteracts 3-nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington\u2019s disease. Metab Brain Dis. 2018;33:1459\u201370.","journal-title":"Metab Brain Dis"},{"key":"558_CR58","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","volume":"129","author":"S Amor","year":"2010","unstructured":"Amor S, Puentes F, Baker D, van der Valk P. Inflammation in neurodegenerative diseases. Immunology. 2010;129:154\u201369.","journal-title":"Immunology."},{"key":"558_CR59","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.1007\/s12035-015-9593-4","volume":"53","author":"L Xu","year":"2015","unstructured":"Xu L, He D, Bai Y. Microglia-mediated inflammation and neurodegenerative disease. Mol Neurobiol. 2015;53:6709\u201315.","journal-title":"Mol Neurobiol"},{"key":"558_CR60","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","volume":"36","author":"AD Thome","year":"2016","unstructured":"Thome AD, Harms AS, Volpicelli-Daley LA, Standaert DG. microRNA-155 Regulates alpha-synuclein-induced inflammatory responses in models of Parkinson disease. J Neurosci. 2016;36:2383\u201390.","journal-title":"J Neurosci"},{"key":"558_CR61","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement (N. Y.). 2018;4:575\u201390.","journal-title":"Alzheimers Dement (N. Y)"},{"key":"558_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29792-x","volume":"8","author":"J Pido-Lopez","year":"2018","unstructured":"Pido-Lopez J, Andre R, Benjamin AC, Ali N, Farag S, Tabrizi SJ, et al. In vivo neutralization of the protagonist role of macrophages during the chronic inflammatory stage of Huntington\u2019s disease. Sci Rep. 2018;8:11447.","journal-title":"Sci Rep."},{"key":"558_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11441-0","volume":"10","author":"JJ Siew","year":"2019","unstructured":"Siew JJ, Chen HM, Chen HY, Chen HL, Chen CM, Soong BW, et al. Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington\u2019s disease. Nat Commun. 2019;10:3473.","journal-title":"Nat Commun"},{"key":"558_CR64","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fncel.2019.00514","volume":"13","author":"CY Liu","year":"2019","unstructured":"Liu CY, Wang X, Liu C, Zhang HL. Pharmacological targeting of microglial activation: New therapeutic approach. Front Cell Neurosci. 2019;13:514.","journal-title":"Front Cell Neurosci"},{"key":"558_CR65","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s12035-019-01847-8","volume":"57","author":"E Paldino","year":"2020","unstructured":"Paldino E, Balducci C, La Vitola P, Artioli L, D\u2019Angelo V, Giamp\u00e0 C, et al. Neuroprotective effects of doxycycline in the R6\/2 mouse model of Huntington\u2019s disease. Mol Neurobiol. 2020;57:1889\u2013903.","journal-title":"Mol Neurobiol"},{"key":"558_CR66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","volume":"44","author":"KH Chang","year":"2015","unstructured":"Chang KH, Wu YR, Chen YC, Chen CM. Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model. Brain Behav Immun. 2015;44:121\u20137.","journal-title":"Brain Behav Immun"},{"key":"558_CR67","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.lfs.2011.02.020","volume":"88","author":"H Kalonia","year":"2011","unstructured":"Kalonia H, Kumar A. Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington\u2019s disease-like alterations in rats. Life Sci. 2011;88:784\u201391.","journal-title":"Life Sci"},{"key":"558_CR68","doi-asserted-by":"publisher","first-page":"116653","DOI":"10.1016\/j.lfs.2019.116653","volume":"232","author":"PAC Valadao","year":"2019","unstructured":"Valadao PAC, Oliveira BDS, Joviano-Santos JV, Vieira ELM, Rocha NP, Teixeira AL, et al. Inflammatory changes in peripheral organs in the BACHD murine model of Huntington\u2019s disease. Life Sci. 2019;232:116653.","journal-title":"Life Sci"},{"key":"558_CR69","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14:133\u201350.","journal-title":"Nat Rev Neurol"},{"key":"558_CR70","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2990.2010.01157.x","volume":"37","author":"J Duran-Vilaregut","year":"2011","unstructured":"Duran-Vilaregut J, del Valle J, Manich G, Camins A, Pall\u00e0s M, Vilaplana J, et al. Role of matrix metalloproteinase-9 (MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington\u2019s disease. Neuropathol Appl Neurobiol. 2011;37:525\u201337.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"558_CR71","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.expneurol.2013.08.019","volume":"250","author":"CY Lin","year":"2013","unstructured":"Lin CY, Hsu YH, Lin MH, Yang TH, Chen HM, Chen YC, et al. Neurovascular abnormalities in humans and mice with Huntington\u2019s disease. Exp Neurol. 2013;250:20\u201330.","journal-title":"Exp Neurol"},{"key":"558_CR72","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3389\/fnins.2019.01168","volume":"13","author":"XQ Gao","year":"2019","unstructured":"Gao XQ, Du ZR, Yuan LJ, Zhang WD, Chen L, Teng JJ, et al. Ginsenoside Rg1 exerts anti-inflammatory effects via G protein-coupled estrogen receptor in lipopolysaccharide-induced microglia activation. Front Neurosci. 2019;13:1168.","journal-title":"Front Neurosci"},{"key":"558_CR73","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jsbmb.2015.09.040","volume":"155","author":"XC Sun","year":"2016","unstructured":"Sun XC, Ren XF, Chen L, Gao XQ, Xie JX, Chen WF. Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra. J Steroid Biochem Mol Biol. 2016;155:94\u2013103.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"558_CR74","doi-asserted-by":"crossref","first-page":"7842082","DOI":"10.1155\/2017\/7842082","volume":"2017","author":"Y Li","year":"2017","unstructured":"Li Y, Guan Y, Wang Y, Yu CL, Zhai FG, Guan LX. Neuroprotective effect of the ginsenoside Rg1 on cerebral ischemic injury in vivo and in vitro is mediated by PPAR\u03b3-regulated antioxidative and anti-inflammatory pathways. Evid Based Complement Altern Med. 2017;2017:7842082.","journal-title":"Evid Based Complement Altern Med"},{"key":"558_CR75","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.brainres.2010.11.069","volume":"1374","author":"JF Hu","year":"2011","unstructured":"Hu JF, Song XY, Chu SF, Chen J, Ji HJ, Chen XY, et al. Inhibitory effect of ginsenoside Rg1 on lipopolysaccharide-induced microglial activation in mice. Brain Res. 2011;1374:8\u201314.","journal-title":"Brain Res"},{"key":"558_CR76","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jneuroim.2013.12.008","volume":"267","author":"RB Laprairie","year":"2014","unstructured":"Laprairie RB, Warford JR, Hutchings S, Robertson GS, Kelly MEM, Denovan-Wright EM. The cytokine and endocannabinoid systems are co-regulated by NF-\u03baB p65\/RelA in cell culture and transgenic mouse models of Huntington\u2019s disease and in striatal tissue from Huntington\u2019s disease patients. J Neuroimmunol. 2014;267:61\u201372.","journal-title":"J Neuroimmunol"},{"key":"558_CR77","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1139\/cjpp-2013-0398","volume":"92","author":"HM Mahdy","year":"2014","unstructured":"Mahdy HM, Mohamed MR, Emam MA, Karim AM, Abdel-Naim AB, Khalifa AE. The anti-apoptotic and anti-inflammatory properties of puerarin attenuate 3-nitropropionic-acid induced neurotoxicity in rats. Can J Physiol Pharm. 2014;92:252\u20138.","journal-title":"Can J Physiol Pharm"},{"key":"558_CR78","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.brainres.2018.06.009","volume":"1697","author":"SY Liu","year":"2018","unstructured":"Liu SY, Yu XL, Zhu J, Liu XM, Zhang Y, Dong QX, et al. Intravenous immunoglobulin ameliorates motor and cognitive deficits and neuropathology in R6\/2 mouse model of Huntington\u2019s disease by decreasing mutant huntingtin protein level and normalizing NF-kappaB signaling pathway. Brain Res. 2018;1697:21\u201333.","journal-title":"Brain Res"},{"key":"558_CR79","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11010-015-2525-9","volume":"409","author":"G Kulasekaran","year":"2015","unstructured":"Kulasekaran G, Ganapasam S. Neuroprotective efficacy of naringin on 3-nitropropionic acid-induced mitochondrial dysfunction through the modulation of Nrf2 signaling pathway in PC12 cells. Mol Cell Biochem. 2015;409:199\u2013211.","journal-title":"Mol Cell Biochem"},{"key":"558_CR80","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bbadis.2011.10.004","volume":"1822","author":"F Fang","year":"2012","unstructured":"Fang F, Chen X, Huang T, Lue LF, Luddy JS, Yan SS. Multi-faced neuroprotective effects of ginsenoside Rg1 in an Alzheimer mouse model. Biochim Biophys Acta. 2012;1822:286\u201392.","journal-title":"Biochim Biophys Acta"},{"key":"558_CR81","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1745-7254.2005.00019.x","volume":"26","author":"XC Chen","year":"2005","unstructured":"Chen XC, Zhou YC, Chen Y, Zhu YG, Fang F, Chen LM. Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress. Acta Pharmacol Sin. 2005;26:56\u201362.","journal-title":"Acta Pharmacol Sin"},{"key":"558_CR82","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41401-020-0358-x","volume":"41","author":"JQ Liu","year":"2020","unstructured":"Liu JQ, Zhao M, Zhang Z, Cui LY, Zhou X, Zhang W, et al. Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-kappaB signaling and modulation of M1\/M2 polarization. Acta Pharmacol Sin. 2020;41:523\u201334.","journal-title":"Acta Pharmacol Sin"},{"key":"558_CR83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41401-018-0154-z","volume":"40","author":"SF Chu","year":"2019","unstructured":"Chu SF, Zhang Z, Zhou X, He WB, Chen C, Luo P, et al. Ginsenoside Rg1 protects against ischemic\/reperfusion-induced neuronal injury through miR-144\/Nrf2\/ARE pathway. Acta Pharmacol Sin. 2019;40:13\u201325.","journal-title":"Acta Pharmacol Sin"},{"key":"558_CR84","first-page":"e13032","volume":"43","author":"Q Shi","year":"2019","unstructured":"Shi Q, He Q, Chen W, Long J, Zhang B. Ginsenoside Rg1 abolish imiquimod\u2010induced psoriasis\u2010like dermatitis in BALB\/c mice via downregulating NF\u2010\u03baB signaling pathway. J Food Biochem. 2019;43:e13032.","journal-title":"J Food Biochem"},{"key":"558_CR85","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.pharep.2019.07.004","volume":"71","author":"J Mo","year":"2019","unstructured":"Mo J, Zhou Y, Yang R, Zhang P, He B, Yang J, et al. Ginsenoside Rg1 ameliorates palmitic acid-induced insulin resistance in HepG2 cells in association with modulating Akt and JNK activity. Pharmacol Rep. 2019;71:1160\u20137.","journal-title":"Pharmacol Rep."},{"key":"558_CR86","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1002\/jcb.29556","volume":"121","author":"M Luo","year":"2020","unstructured":"Luo M, Yan D, Sun Q, Tao J, Xu L, Sun H, et al. Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and inflammation via the TLR4\/NF\u2010kB\/NLRP3 pathway. J Cell Biochem. 2020;121:2994\u20133004.","journal-title":"J Cell Biochem"},{"key":"558_CR87","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2019.02.018","volume":"853","author":"T Zheng","year":"2019","unstructured":"Zheng T, Jiang H, Jin R, Zhao Y, Bai Y, Xu H, et al. Ginsenoside Rg1 attenuates protein aggregation and inflammatory response following cerebral ischemia and reperfusion injury. Eur J Pharmacol. 2019;853:65\u201373.","journal-title":"Eur J Pharmacol"},{"key":"558_CR88","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.lfs.2012.08.028","volume":"91","author":"W Li","year":"2012","unstructured":"Li W, Chu Y, Zhang L, Yin L, Li L. Ginsenoside Rg1 attenuates tau phosphorylation in SK-N-SH induced by A\u03b2\u2010stimulated THP-1 supernatant and the involvement of p38 pathway activation. Life Sci. 2012;91:809\u201315.","journal-title":"Life Sci"},{"key":"558_CR89","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.bbagen.2011.12.005","volume":"1820","author":"C Shi","year":"2012","unstructured":"Shi C, Zheng DD, Fang L, Wu F, Kwong WH, Xu J. Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK\/ERK and PI3K\/Akt. Biochim Biophys Acta. 2012;1820:453\u201360.","journal-title":"Biochim Biophys Acta"},{"key":"558_CR90","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jep.2009.09.038","volume":"127","author":"KL Ge","year":"2010","unstructured":"Ge KL, Chen WF, Xie JX, Wong MS. Ginsenoside Rg1 protects against 6-OHDA-induced toxicity in MES23.5 cells via Akt and ERK signaling pathways. J Ethnopharmacol. 2010;127:118\u201323.","journal-title":"J Ethnopharmacol"},{"key":"558_CR91","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.intimp.2018.04.040","volume":"60","author":"Y Ye","year":"2018","unstructured":"Ye Y, Shan Y, Bao C, Hu Y, Wang L. Ginsenoside Rg1 protects against hind-limb ischemia reperfusion induced lung injury via NF-\u03baB\/COX-2 signaling pathway. Int Immunopharmacol. 2018;60:96\u2013103.","journal-title":"Int Immunopharmacol"},{"key":"558_CR92","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jff.2015.04.010","volume":"15","author":"XJ Zhang","year":"2015","unstructured":"Zhang XJ, He C, Li P, Su H, Wan JB. Ginsenoside Rg1, a potential JNK inhibitor, protects against ischemia\/reperfusion-induced liver damage. J Funct Foods. 2015;15:580\u201392.","journal-title":"J Funct Foods"},{"key":"558_CR93","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.3389\/fimmu.2018.02889","volume":"9","author":"C Fan","year":"2018","unstructured":"Fan C, Song Q, Wang P, Li Y, Yang M, Yu SY. Neuroprotective effects of ginsenoside-Rg1 against depression-like behaviors via suppressing glial activation, synaptic deficits, and neuronal apoptosis in rats. Front Immunol. 2018;9:2889.","journal-title":"Front Immunol"},{"key":"558_CR94","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s11064-018-2615-7","volume":"43","author":"P Liu","year":"2018","unstructured":"Liu P, Li Y, Liu D, Ji X, Chi T, Li L, et al. Tolfenamic acid attenuates 3-nitropropionic acid-induced biochemical alteration in mice. Neurochem Res. 2018;43:1938\u201346.","journal-title":"Neurochem Res"},{"key":"558_CR95","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-brain barrier: From physiology to disease and back. Physiol Rev. 2019;99:21\u201378.","journal-title":"Physiol Rev"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00558-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T17:27:16Z","timestamp":1723915636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00558-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":95,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["558"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-00558-4","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}